VESIcare LS Approved for Neurogenic Detrusor Overactivity

WEDNESDAY, May 27, 2020 — VESIcare LS (solifenacin succinate) oral suspension is now approved to treat neurogenic detrusor overactivity (NDO) in children 2 years and older, the U.S. Food and Drug Administration announced Tuesday.
VESIcare…
Source: Topamax